The Bill Nobody's Discussing in the Exam Room Head and neck cancer costs are crushing patients — yet cost discussions remain uncommon in clinical care. By Kerri Miller May 11, 2026 2 min MDSpire News Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll 1 Only 15% of cancer patients have financial discussions with their care team, despite over 90% wanting such conversations. 2 Head and neck cancer treatment is costly, often requiring multimodal approaches that increase overall expenses. 3 Cost conversations in oncology are linked to lower out-of-pocket costs, better treatment adherence, and higher patient satisfaction. 4 Patients from disadvantaged backgrounds are less likely to initiate financial discussions, risking their financial hardships being overlooked. 5 Routine financial screening in clinical practice is recommended to improve patient care and reduce stigma associated with financial concerns.
